Agomelatine-induced modulation of brain-derived neurotrophic factor (BDNF) in the rat hippocampus
The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
&NA; Brain‐derived neurotrophic factor (BDNF) is a neurotrophin that serves as a survival factor for neurons. Agomelatine is a novel antidepressant as well as a potent agonist of melatonin (MT), MT1 and MT2 receptor types and an antagonist of the serotonin (5HT), 5‐HT2C receptor. The study herein established whether treatment with agomelatine alters hippocampal BDNF protein expression under chronic unpredictable mild stress (CUMS) condition. Twenty‐one day treatment with agomelatine, fluoxetine or vehicle was assessed in 52 Sprague‐Dawley rats undergoing CUMS. Ten naïve control rats were also evaluated after 21 days. The behavioral effects of treatments were studied using the open field test (OFT) on day 0, 7 and 21 and sucrose preference test on day 21. Hippocampal BDNF protein expression was measured using immunohistochemistry. The effect of the interventions on hippocampal neurons was histologically examined after H&E staining. Agomelatine mitigated the reduction in rearing behavior by CUMS in the OFT on day 7 as well as sucrose preference on day 21. The mean optical density value of BDNF was significantly higher in the CUMS + agomelatine group than the CUMS and CUMS + fluoxetine groups. The CUMS + agomelatine group had a significantly higher number of BDNF positive cells compared to naïve controls and CUMS group. Histology showed that hippocampal neurons in the CUMS + agomelatine and CUMS + fluoxetine groups were intact and few of them demonstrated karyopyknosis. Agomelatine–a novel antidepressant, but not fluoxetine, increased hippocampal BDNF level and of BDNF positive neurons in rats subject to CUMS. HighlightsAgomelatine is a novel antidepressant and agonist of MT, MT1 and MT2 receptors and antagonist of 5‐HT, 5‐HT2C receptor.Agomelatine alleviated reduction in locomotor activity (rearing) and anhedonia (sucrose preference rate) caused by CUMS.Agomelatine increased hippocampal BDNF expression and number of BDNF positive neurons in rats subject to CUMS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
BDNF and Activity-Dependent Synaptic Modulation: Figure 1.
Lu, B. (2003) · Learning & Memory · doi:10.1101/lm.54603 · Cited by 945
McIntyre, R. S., Cha, D. S., Soczynska, J. K., Woldeyohannes, H. O., Gallaugher, L. A., Kudlow, P., Alsuwaidan, M., & Baskaran, A. (2013) · Depression and Anxiety · doi:10.1002/da.22063 · Cited by 765
Self-citationRodent models in neuroscience research: is it a rat race?
Ellenbroek, B., & Youn, J. (2016) · Disease Models & Mechanisms · doi:10.1242/dmm.026120 · Cited by 627
OPEN‐FIELD BEHAVIOR IN THE RAT: WHAT DOES IT MEAN?*
Denenberg, V. H. (1969) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1969.tb12983.x · Cited by 582
Animal model of depression: Pharmacological sensitivity of a hedonic deficit
Katz, R. J. (1982) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(82)90053-3 · Cited by 480
de Foubert, G., Carney, S. L., Robinson, C. S., Destexhe, E. J., Tomlinson, R., Hicks, C. A., Murray, T. K., Gaillard, J. P., Deville, C., Xhenseval, V., et al. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.06.054 · Cited by 249
Zhou, C., Zhong, J., Zou, B., Fang, L., Chen, J., Deng, X., Zhang, L., Zhao, X., Qu, Z., Lei, Y., et al. (2017) · PLOS ONE · doi:10.1371/journal.pone.0172270 · Cited by 187
Lu, Y., Ho, C. S., Liu, X., Chua, A. N., Wang, W., McIntyre, R. S., & Ho, R. C. (2017) · PLOS ONE · doi:10.1371/journal.pone.0186700 · Cited by 164
Self-citationFornaro, M., McCarthy, M. J., De Berardis, D., Pasquale, D., Martino, Colicchio, Cattaneo, D'Angelo, Fornaro, P., & Tabaton (2013) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s41557 · Cited by 67
Gupta, R., Gupta, K., Tripathi, A. K., Bhatia, M. S., & Gupta, L. K. (2016) · Pharmacology · doi:10.1159/000444220 · Cited by 61
Cited by
Almeida, R. N. D., Galvão, A. C. D. M., da Silva, F. S., Silva, E. A. D. S., Palhano-Fontes, F., Maia-de-Oliveira, J. P., de Araújo, L.-S. B., Lobão-Soares, B., & Galvão-Coelho, N. L. (2019) · Frontiers in Psychology · doi:10.3389/fpsyg.2019.01234 · Cited by 177
Cao, B., Zhu, J., Zuckerman, H., Rosenblat, J. D., Brietzke, E., Pan, Z., Subramanieapillai, M., Park, C., Lee, Y., & McIntyre, R. S. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.01.002 · Cited by 175
“Additionally, agomelatine has been found to increase the number of BDNF positive neurons in animal models of depression (Lu et al., 2018a).”
BackgroundSelf-citationCognitive Control as a 5-HT1A-Based Domain That Is Disrupted in Major Depressive Disorder
Langenecker, S. A., Mickey, B. J., Eichhammer, P., Sen, S., Elverman, K. H., Kennedy, S. E., Heitzeg, M. M., Ribeiro, S. M., Love, T. M., Hsu, D. T., et al. (2019) · Frontiers in Psychology · doi:10.3389/fpsyg.2019.00691 · Cited by 18
“Novel antidepressants including agomelatine and vortioxetine induced modulation of brainderived neurotrophic factor (BDNF) which is a neurotrophin that serves as a survival factor for neurons (Lu et al., 2018a,b).”
Background
Metadata
- Authors
- Lu, Y., Ho, C. S., McIntyre, R. S., Wang, W., & Ho, R. C.
- Venue
- Life Sciences
- Publisher
- Elsevier BV
- Published
- 2018-10
- Volume
- 210
- Pages
- 177-184
- ISSN
- 0024-3205 (ISSN-L)
- OpenAlex
- W2891721556
- Cited by
- 76
- References
- 12
- FWCI
- 5.55
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Agomelatine-induced modulation of brain-derived neurotrophic factor (BDNF) in the rat hippocampus. https://app.cochat.ai/papers/10.1016/j.lfs.2018.09.003
- The paper
- Lu, Y., Ho, C. S., McIntyre, R. S., Wang, W., & Ho, R. C. (2018). Agomelatine-induced modulation of brain-derived neurotrophic factor (BDNF) in the rat hippocampus. Life Sciences. https://doi.org/10.1016/j.lfs.2018.09.003
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.